Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Aug 2014 15:36

RNS Number : 6618P
Circassia Pharmaceuticals Plc
20 August 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Circassia Pharmaceuticals Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

ODEY ASSET MANAGEMENT LLP

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

19 AUGUST 2014

6. Date on which issuer notified:

 20 AUGUST 2014

7. Threshold(s) that is/are crossed orreached: vi, vii

9%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Share

(GB00BJVD3B28)

17,282,975

17,282,975

16,516,301

16,516,301

8.72%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Ordinary Shares

8.72%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

All Odey funds hold less than 3%.

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Shermin Goodluck

15. Contact telephone number:

01865 405560

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUROSRSSAWUAR
Date   Source Headline
31st Jan 20184:03 pmRNSTotal Voting Rights
17th Jan 20182:42 pmRNSBlock Listing Six Monthly Return
17th Jan 20182:37 pmRNSNotification of Major Holdings
8th Jan 20187:00 amRNSTR-1: Notification of major holdings
5th Jan 20185:31 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSTotal Voting Rights
19th Dec 20175:48 pmRNSNotification of Major Holdings
4th Dec 20177:00 amRNSTudorza® Meets Primary Endpoints in ASCENT Study
30th Nov 20172:53 pmRNSTotal Voting Rights
29th Nov 20177:00 amRNSCircassia Welcomes New NICEAsthma Guidelines
31st Oct 20175:18 pmRNSTotal Voting Rights Update
16th Oct 201711:39 amRNSNotification of Major Holdings
29th Sep 201712:13 pmRNSTotal Voting Rights Update
27th Sep 20177:00 amRNSInterim results six months ended 30 June 2017
18th Sep 20172:52 pmRNSNotification of Major Holdings
18th Sep 20172:19 pmRNSNotification of Major Holdings
12th Sep 20177:00 amRNSEuropean Launch of NIOX VERO® Nasal Mode
7th Sep 20177:00 amRNSPrimary Endpoints Met in AMPLIFY Phase III Study
1st Sep 20175:21 pmRNSNotification of Major Holdings
31st Aug 201712:52 pmRNSTotal Voting Rights
24th Aug 20174:06 pmRNSNotice of Interim Results
31st Jul 20177:00 amRNSTotal Voting Rights Update
21st Jul 20178:52 amRNSNotification of Major Holdings
17th Jul 20176:28 pmRNSDirector/PDMR Shareholding
14th Jul 201712:29 pmRNSNotification of Major Holdings
30th Jun 20177:00 amRNSBlock Listing Six Monthly Return
30th Jun 20177:00 amRNSTotal Voting Rights Update
29th Jun 20176:08 pmRNSNotification of Major Interest in Shares
27th Jun 201711:48 amRNSNotification of Major Interest in Shares
26th Jun 20174:27 pmRNSNotification of Major Interest in Shares
15th Jun 20175:40 pmRNSNotification of Major Interest in Shares
5th Jun 20175:36 pmRNSDirector/PDMR Shareholding
31st May 201710:59 amRNSTotal Voting Rights Update
31st May 20177:00 amRNSBlock Listing Application
26th May 201711:35 amRNSResult of AGM 2017
26th May 20177:00 amRNSHolding(s) in Company
28th Apr 20175:20 pmRNSAnnual Report and Notice of Annual General Meeting
28th Apr 20173:15 pmRNSTotal Voting Rights Update
25th Apr 20177:02 amRNSNon-Executive Director Retirements
25th Apr 20177:00 amRNSPreliminary Results for Year Ended 31 Dec 2016
18th Apr 20176:09 pmRNSHolding(s) in Company
18th Apr 20174:51 pmRNSNotification of Major Interest in Shares
18th Apr 201710:20 amRNSNotification of Major Interest in Shares
18th Apr 20177:00 amRNSTop-Line Results of House Dust Mite Allergy Study
13th Apr 20176:02 pmRNSHolding(s) in Company
13th Apr 20175:57 pmRNSHolding(s) in Company
12th Apr 20175:34 pmRNSNotification of Major Interest in Shares
12th Apr 20179:00 amRNSNotice of Results
12th Apr 20178:30 amRNSCompletion of Transaction and Admission to Trading
11th Apr 20179:00 amRNSEarly Termination of HSR Waiting Period Granted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.